The effectiveness of high molecular weight hyaluronic acid for knee osteoarthritis in patients in the working age: a randomised controlled trial

被引:44
|
作者
Hermans, Job [1 ]
Bierma-Zeinstra, Sita M. A. [1 ,2 ]
Bos, Pieter K. [1 ]
Niesten, Dieu Donne [3 ]
Verhaar, Jan A. N. [1 ]
Reijman, Max [1 ]
机构
[1] Erasmus Univ, Dept Orthopaed Surg, Med Ctr Rotterdam, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Dept Gen Practice, Med Ctr, POB 2040, NL-3000 CA Rotterdam, Netherlands
[3] Reinier de Graaf Hosp, Dept Orthopaed Surg, POB 5011, NL-2600 GA Delft, Netherlands
关键词
Knee osteoarthritis; Hyaluronic acid; Effectiveness; Randomised controlled trial; Working age; TASK-FORCE; MANAGEMENT; EFFICACY; SOCIETY; BURDEN; COSTS; RISK; HIP;
D O I
10.1186/s12891-019-2546-8
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
BackgroundHigh molecular weight (HMW) hyaluronic acid (HA) is a treatment option for knee osteoarthritis (OA). The efficacy of HMW-HA in knee OA is investigated extensively, but the effectiveness in patients in the working age is unknown. Nevertheless, the number knee OA patients in the working age is increasing. Surgical treatment options are less eligible in these patients and productivity losses are high. In this study the effectiveness of intra-articular HMW-HA added to regular non-surgical usual care in everyday clinical practice (UC) compared to UC over 52weeks in symptomatic knee OA patients in the working age was investigated.MethodsIn this open labelled randomized controlled trial, subjects aged between 18 and 65years with symptomatic knee OA (Kellgren and Lawrence I-III) were enrolled and randomized to UC+3 weekly injections with HMW-HA (intervention) or UC only (control). The primary outcome was the between group difference in responders to therapy according to OMERACT-OARSI criteria after 52weeks. These criteria include the domains pain, knee related function and patient's global assessment (PGA). Function was evaluated with the KOOS questionnaire. Pain was assessed with the Numeric Rating Scale. Secondary outcome comprised the between group difference on the individual responder domains, as analysed with a random effects model. Odds Ratios (OR) were calculated by logistic regression analysis. Sensitivity analyses were performed.ResultsIn total, 156 subjects were included (intervention group 77, control group 79). Subjects in the intervention group (HMW-HA+UC) were more often responder compared to the controls (UC). Depending on whether pain during rest or pain during activity was included in the responder domains, 57.1% versus 34.2% (p=0.006) and 54.5% versus 34.2% (p=0.015) was responder to therapy respectively. The results of the secondary outcome analyses show that scores on individual responder domains over all follow-up moments were statistically significant in favour of the intervention group in the domains pain during rest ( 0.8, 95%CI 0.2; 1.4, p=0.010), knee related function ( -6.8, 95%CI -11.9; -1.7, p=0.010) and PGA ( -0.7, 95%CI -0.9; -0.4, p<0.0001).ConclusionsIntra-articular HMW-HA added to usual care is effective for knee OA in patients in the working age.Trial registrationwww.trialregister.nl, NTR1651, registered 2009-3-3.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] A Randomised Controlled Trial of YOGa and Strengthening Exercise for Knee OsteoArthritis: Protocol for a Comparative Effectiveness Trial (YOGA Trial)
    Singh, Ambrish
    Aitken, Dawn
    Moonaz, Steffany
    Palmer, Andrew J.
    Blizzard, Leigh
    Ding, Changhai
    Drummen, Stan
    Jones, Graeme
    Bennell, Kim
    Antony, Benny
    JOURNAL OF FUNCTIONAL MORPHOLOGY AND KINESIOLOGY, 2022, 7 (04)
  • [42] A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis
    Kotevoglu, N
    Iyibozkurt, PC
    Hiz, O
    Toktas, H
    Kuran, B
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (04) : 325 - 330
  • [43] Acupuncture in patients with osteoarthritis of the knee: a randomised trial
    Kluger, Rainer
    DEUTSCHE ZEITSCHRIFT FUR AKUPUNKTUR, 2006, 49 (02): : 45 - 46
  • [44] Acupuncture in patients with osteoarthritis of the knee: a randomised trial
    Witt, C
    Brinkhaus, B
    Jena, S
    Linde, K
    Streng, A
    Wagenpfeil, S
    Hummelsberger, J
    Walther, HU
    Melchart, D
    Willich, SN
    LANCET, 2005, 366 (9480): : 136 - 143
  • [45] The effectiveness of injections of hyaluronic acid or corticosteroid in patients with subacromial impingement A THREE-ARM RANDOMISED CONTROLLED TRIAL
    Penning, L. I. F.
    de Bie, R. A.
    Walenkamp, G. H. I. M.
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2012, 94B (09): : 1246 - 1252
  • [46] THERAPEUTIC EFFECT OF INTRA-ARTICULAR INJECTION OF HIGH MOLECULAR-WEIGHT HYALURONIC-ACID ON OSTEOARTHRITIS OF THE KNEE
    NAMIKI, O
    TOYOSHIMA, H
    MORISAKI, N
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1982, 20 (11) : 501 - 507
  • [47] Chondroprotective effects of high-molecular-weight cross-linked hyaluronic acid in a rabbit knee osteoarthritis model
    Elmorsy, S.
    Funakoshi, T.
    Sasazawa, F.
    Todoh, M.
    Tadano, S.
    Iwasaki, N.
    OSTEOARTHRITIS AND CARTILAGE, 2014, 22 (01) : 121 - 127
  • [48] Weight loss: The treatment of choice for knee osteoarthritis? A randomised trial
    Christensen, R
    Astrup, A
    Bliddal, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 86 - 87
  • [49] A MULTICENTRE RANDOMISED CONTROLLED TRIAL OF ZOLEDRONIC ACID FOR OSTEOARTHRITIS OF THE KNEE WITH BONE MARROW LESIONS
    Cai, G.
    Aitken, D.
    Laslett, L.
    Hill, C.
    March, L.
    Wluka, A. E.
    Wang, Y.
    Blizzard, L.
    Cicuttini, F.
    Winzenberg, T.
    Jones, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 57 - 58
  • [50] Efficacy of single high-molecular-weight versus triple low-molecular-weight hyaluronic acid intra-articular injection among knee osteoarthritis patients
    Mohammad Hasan Bahrami
    Seyed Ahmad Raeissadat
    Mohsen Cheraghi
    Shahram Rahimi-Dehgolan
    Adel Ebrahimpour
    BMC Musculoskeletal Disorders, 21